Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The diagnosis and monitoring of ear related problems usually requires examination of the ear and a hearing test and this is
currently carried out at the GP surgery or in outpatient clinics, as existing equipment is not suitable for remote use. Bringing
care closer to home could significantly improve the patientâ??s experience and prevent unnecessary trips to the hospital. Itâ??s particularly
important for parents as 90% of children have an ear condition before the age of 6 and 50% of those are recurring. Itâ??s estimated that
30-40% of people with learning disabilities (PWLD) have significant hearing loss and this particularly vulnerable population can find
the process of attending an appointment and the subsequent examination difficult, intrusive and can cause anxiety. This results in
many PWLD remaining undiagnosed and unaware of their condition. Medway NHS Foundation Trust is launching a trial to evaluate
Cuprisâ?? novel digital system to allow the remote diagnosis and monitoring of ear conditions. It comprises: A smart-phone connected
otoscope that allows clinical images of the eardrum
to be taken; An inapp
hearing screening test conducted on the smart-phone and a
communication platform (app and website) to enhance communications between healthcare stakeholders, including the patient. The
users can capture clinical images of patient conditions using their smart-phones, add information using skip-logic questionnaires,
audio recordings, text input and other tools built into the smart-phone app, securely connect with other Cupris Health users to share
cases with them through the cloud service and discuss and monitor patient cases and receive diagnoses of patient conditions without
seeing patients in person. The study will be conducted over 6 months in different settings: GP practices, care homes, ENT clinics and
patientsâ?? homes. It will assess the quality of the Cupris device (otoscope and hearing screening test) as well as the communication
system on several aspects: impact on the patientâ??s healthcare experience, acceptability for patients and healthcare professionals, health
economic impact and number of appointments that could be prevented. The communication software assessment will be run on two
main streams: primary care (carer or patient contacting GP) and secondary care (GP referring to ENT specialist). Cupris digital health
technology will improve healthcare delivery by making it easier and more efficient and by enabling better communication between
healthcare professionals and non-healthcare professionals. It is expected that it will show a significant reduction in the number of
unnecessary referrals or avoidable appointments. It will give patients the opportunity to receive a diagnosis from the comfort of their
home or closer to their home, as well as empowering both patients and non-specialist healthcare-professionals by enabling them to
visualize conditions, understand them better and have greater transparency with the overall treatment.